Ivermectin is the most recent example of a medication touted as miracle drug for COVID-19 without solid medical evidence supporting its use.
Shares of Humanigen plunged in trading after the company announced the U.S. Food and Drug Administration rejected the company’s Emergency Use Authorization request for lenzilumab, a potential treatment...
The Bill & Melinda Gates Foundation must have liked what it saw in an initial collaboration with Exscientia The post Gates Foundation ramps up funding to...
Indian drug developer Hetero received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's Covid-19 drug.
Pfizer Inc. started dosing in a mid-to-late-stage trial of the company's oral antiviral therapy for Covid-19 in non-hospitalized, symptomatic adult patients.
The COVID-19 pandemic has highlighted the importance of ensuring a reliable supply of treatments across the globe at The post Improving access to treatments in challenging...
Ion channels may be the Achilles’ heel of the SARS-CoV-2 virus, with research emerging from Israel that identified eight already-approved compounds that inhibit the activity of...
Research published in Trends in Genetics by Dr. Leslie Lyons, Gilbreath-McLorn endowed professor of comparative medicine at the University of Missouri College of Veterinary Medicine, could be instrumental...
A large, randomized, placebo-controlled trial found that the administration of Covid-19 convalescent plasma to high-risk outpatients did not prevent the progression of Covid-19, according to results...
Health Canada has started a rolling review of Merck & Co’s molnupiravir, an oral antiviral therapy treatment for The post Merck kicks off oral COVID-19 antiviral...
An antiviral treatment under development by Atea Pharmaceuticals is showing promise against Covid-19.
India's Ivermectin Blackout Authored by Justus R Hope, MD. via TheDesertReview.com, Ivermectin Wins in India News of India's defeat of the Delta variant should be common...
The World Health Organization (WHO) said on Aug. 11 a clinical trial in 52 countries would study three anti-inflammatory drugs as potential treatments for Covid-19 patients.
Gilead Sciences announced on Aug. 9 that the company will require employees and contractors to be fully vaccinated against the novel coronavirus by Oct. 1.
Gilead Sciences (GILD) is a major biotechnology company that is focused on virus infection treatments. The company's biggest business unit is its HIV franchise, which generates...
Gilead Sciences will open the doors to the company's new operations site in North Raleigh, N.C., as part of a business services center expansion. Gilead’s second-quarter 2021...
The U.S. health regulator expanded the emergency use authorization for Eli Lilly's baricitinib for Covid-19, saying the arthritis medicine could now be used without taking Gilead's...
Continuing orders for Pfizer’s BioNTech-partnered COVID-19 vaccine Comirnaty have prompted near one-third increase in its projected revenues for The post Pfizer hikes COVID vaccine sales forecast...
Who Watches The Watchmen? - Fauci's "Noble Lie" Exposed Authored by Charles Rixey via Prometheus Shrugged, *Note — This article details current historical research into COVID-19’s...
Researchers in Canada have built a computer model that replicates how the human immune system interacts with the The post Computer model simulates COVID infection, and...
Indonesia Regulator Allows Ivermectin Use For Covid Treatment Merely mentioning the name of the vaccine-busting drug Ivermectin in the US is enough to get you carted...
Since the early days of the pandemic, drugmakers have taken a broad approach to repurposing other drugs in their pipeline against severe Covid-19 — a mission...
Thanks to unprecedented development speed and mostly strong safety and efficacy data, vaccines have dominated the response to COVID-19. Seven COVID-19 drugs have shown promise recently....
Lexaria Bioscience (NASDAQ:LEXX,CSE:LXX) concluded its expanded research program for DehydraTECH-enabled remdesivir and ebastine, showing effective results in inhibiting the COVID-19 SARS-CoV-2 virus. Lexaria Bioscience CEO Chris...
The U.S. Food and Drug Administration has granted Genentech a member of the Roche Group, EUA for its marketed interleukin-6 (IL-6) receptor antagonist Actemra® (tocilizumab) as...
Roche has been granted emergency approval by the FDA for its arthritis drug Actemra
Supply chains, choke points, and 'just in time' manufacturing – where things went right and wrong during the pandemic.
Gilead Sciences Inc. said an analysis showed the company's antiviral remdesivir reduced mortality rates in hospitalized patients with Covid-19 and increased the likelihood of being discharged...
Paul Burton → Apparently Tal Zaks took George Costanza’s concept on Seinfeld of going out on a high note to heart at Moderna, making his plans...
The Biden Administration has said it will allocate $3 billion of its pandemic rescue plan to the development The post White House pledges $3 billion war...